iPS cell technologies: significance and applications to CNS regeneration and disease
暂无分享,去创建一个
[1] Nobutaka Hattori,et al. PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy , 2012, Scientific Reports.
[2] H. Weintraub,et al. Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.
[3] G. Pellegrini,et al. Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa , 2013, Stem cell reports.
[4] H. Okano,et al. Generation of Stratified Squamous Epithelial Progenitor Cells from Mouse Induced Pluripotent Stem Cells , 2011, PloS one.
[5] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[6] T. Shimazaki,et al. Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development , 2008, Nature Neuroscience.
[7] A. Koizumi,et al. Spatiotemporal Recapitulation of Central Nervous System Development by Murine Embryonic Stem Cell‐Derived Neural Stem/Progenitor Cells , 2008, Stem cells.
[8] Elo Leung,et al. A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.
[9] J. Mertens,et al. Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease , 2011, Nature.
[10] S. Tsuji. Genetics of neurodegenerative diseases: insights from high-throughput resequencing , 2010, Human molecular genetics.
[11] H. Okano,et al. Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: Utility and limitation of the surrogate tissues in research for brain disorders , 2013, Neuroscience Research.
[12] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[13] H. Okano,et al. Transplantation of in vitro‐expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats , 2002, Journal of neuroscience research.
[14] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[15] C. Klein,et al. Impact of recent genetic findings in Parkinson's disease , 2007, Current opinion in neurology.
[16] L. Laurent,et al. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability. , 2010, Cell stem cell.
[17] I. Wilmut,et al. "Viable Offspring Derived from Fetal and Adult Mammalian Cells" (1997), by Ian Wilmut et al. , 2014 .
[18] K. Garber. Inducing translation , 2013, Nature Biotechnology.
[19] C. Mummery,et al. From Stealing Fire to Cellular Reprogramming: A Scientific History Leading to the 2012 Nobel Prize , 2013, Stem cell reports.
[20] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[21] Fred H. Gage,et al. Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.
[22] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[23] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[24] Y. Hoki,et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.
[25] Takashi Daimon,et al. Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.
[26] B. Doble,et al. The ground state of embryonic stem cell self-renewal , 2008, Nature.
[27] Satoshi Nishimura,et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. , 2014, Cell stem cell.
[28] G. Martin,et al. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Viale,et al. Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.
[30] A. Toyoda,et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. , 2009, Archives of neurology.
[31] Ji Young Kim,et al. Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patients , 2011, Annals of neurology.
[32] Patrick A. Lewis,et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.
[33] F. Gage,et al. Modeling brain disease in a dish: really? , 2012, Cell stem cell.
[34] Kristopher L. Nazor,et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.
[35] H. Okano,et al. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.
[36] G. Daley,et al. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. , 2010, Cell stem cell.
[37] M. Yamato,et al. Generation of Corneal Epithelial Cells from Induced Pluripotent Stem Cells Derived from Human Dermal Fibroblast and Corneal Limbal Epithelium , 2012, PloS one.
[38] Jan Gründemann,et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.
[39] D. Krainc,et al. Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.
[40] A. Brice,et al. What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.
[41] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[42] N. Ghebranious,et al. Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology , 2005, Nucleic acids research.
[43] Robert C. Thompson,et al. The More, the Better: Modeling Dravet Syndrome With Induced Pluripotent Stem Cell-Derived Neurons , 2014 .
[44] J. Mertens,et al. APP Processing in Human Pluripotent Stem Cell-Derived Neurons Is Resistant to NSAID-Based γ-Secretase Modulation , 2013, Stem cell reports.
[45] L. Forno,et al. Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.
[46] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[47] Katsuhiro Yoshikawa,et al. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. , 2013, Cell stem cell.
[48] C. Svendsen,et al. Induced pluripotent stem cells: a new revolution for clinical neurology? , 2011, The Lancet Neurology.
[49] H. Okano,et al. Modeling human neurological disorders with induced pluripotent stem cells , 2014, Journal of neurochemistry.
[50] Junichi Kiryu,et al. Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application , 2014, Stem cell reports.
[51] D. Balota,et al. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). , 2014, Neuropsychology.
[52] Hideyuki Okano,et al. Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity , 2012, PloS one.
[53] Daniel T. Montoro,et al. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells , 2010, PLoS currents.
[54] J. Gurdon,et al. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. , 1962, Journal of embryology and experimental morphology.
[55] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[56] H. Okano,et al. Enhanced Aggregation of Androgen Receptor in Induced Pluripotent Stem Cell-derived Neurons from Spinal and Bulbar Muscular Atrophy* , 2013, The Journal of Biological Chemistry.
[57] K. Kasai,et al. Increased L1 Retrotransposition in the Neuronal Genome in Schizophrenia , 2014, Neuron.
[58] Keiichiro Suzuki,et al. Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[59] K. Sekiguchi,et al. Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation , 2014, Stem cell reports.
[60] Torsten Kluba,et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.
[61] H. Okano,et al. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord , 2006, Nature Medicine.
[62] K. Nabeshima,et al. A human Dravet syndrome model from patient induced pluripotent stem cells , 2013, Molecular Brain.
[63] K. Mikoshiba,et al. Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. , 1996, Developmental biology.
[64] John K. Heath,et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.
[65] Hideyuki Okano,et al. Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells , 2013, Circulation research.
[66] H. Onoe,et al. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. , 2011, Journal of Parkinson's disease.
[67] H. Okano,et al. Fibroblast growth factor‐2/brain‐derived neurotrophic factor—associated maturation of new neurons generated from adult human subependymal cells , 1998, Annals of neurology.
[68] Blake Byers,et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.
[69] H. Hioki,et al. Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells , 2012, Science Translational Medicine.
[70] Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury , 2013, Molecular Brain.
[71] S. Mastana,et al. Genetic Variation of Apolipoproteins in North Indians , 2002, Human biology.
[72] H. Okano,et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. , 2011, Human molecular genetics.
[73] Nicholas G Martin,et al. Toward the development of a global induced pluripotent stem cell library. , 2013, Cell stem cell.
[74] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[75] Randall J Bateman,et al. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials , 2013, Alzheimer's Research & Therapy.
[76] S. Yamanaka,et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells , 2010, The Journal of experimental medicine.
[77] H. Okano,et al. Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells , 2012, Cell Research.
[78] R A Crowther,et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.
[79] S. Yuasa,et al. Induced Pluripotent Stem Cells in Cardiovascular Medicine , 2011, Stem cells international.
[80] D. Krainc,et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.
[81] MasashiKawamura,et al. Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012 .
[82] S. Yamanaka. Induced pluripotent stem cells: past, present, and future. , 2012, Cell stem cell.
[83] H. Okano,et al. Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice , 2011, Proceedings of the National Academy of Sciences.
[84] Fred H. Gage,et al. A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.
[85] H. Okano,et al. Transplantation of human neural stem cells for spinal cord injury in primates , 2005, Journal of neuroscience research.
[86] Hynek Wichterle,et al. Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.
[87] Yang Xu,et al. Immunogenicity of induced pluripotent stem cells , 2011, Nature.
[88] C. E. Pearson,et al. Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation. , 2011, Human molecular genetics.
[89] E. Bouhassira,et al. Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells. , 2012, Blood.
[90] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[91] H. Okano,et al. Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/β-catenin signaling. , 2013, Stem cells and development.
[92] A. Muotri,et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients , 2011, Human molecular genetics.
[93] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[94] Hideyuki Okano,et al. Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.
[95] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[96] Hideyuki Okano,et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury , 2010, Proceedings of the National Academy of Sciences.
[97] T. Iwatsubo,et al. Disease‐modifying therapy for Alzheimer's disease: Challenges and hopes , 2013 .
[98] Norio Nakatsuji,et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells , 2001, Current Biology.
[99] Jiao Jiao,et al. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons. , 2013, Human molecular genetics.
[100] Shinya Yamanaka,et al. Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.
[101] James A. Thomson,et al. Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.
[102] M. Elisaf,et al. Apolipoprotein E and renal disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[103] Andrew J. Saykin,et al. The pattern of atrophy in familial Alzheimer disease , 2013, Neurology.